A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Clinical trial NCT07082920 · RECRUITING

Trial details

NCT number: NCT07082920
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2025-07-07
Primary completion: 2027-01-28
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.